Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

Kidney International Reports（2023）

引用 6|浏览11

暂无评分

摘要

Among patients with baseline eGFR ≤20 ml/min per 1.73 m in the ADVOCATE trial, eGFR improved more in the avacopan group than in the prednisone group.

查看译文

关键词

ANCA-associated vasculitis,avacopan,complement,complement 5a receptor,low eGFR,renal recovery

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要